Cargando…
Dexamethasone: Chronic cavitary pulmonary aspergillosis and off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023731/ http://dx.doi.org/10.1007/s40278-022-13716-2 |
Ejemplares similares
-
Dexamethasone: Pulmonary mucormycosis, pulmonary aspergillosis and off-label use: case report
Publicado: (2021) -
Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2021) -
Chronic cavitary pulmonary aspergillosis in an immunocompetent child
por: Davies, Adeyinka A., et al.
Publicado: (2022) -
Azithromycin/dexamethasone/methylprednisolone: Aspergillosis, mucormycosis and off-label use: case report
Publicado: (2022) -
Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report
Publicado: (2021)